US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Xpedra Resources Ltd (PK) (VOYRF) 銘柄情報

Xpedra Resources Ltd (PK) (VOYRF)

0.0136

0.00

(0.00%)

終了 7月4日 5:00AM

Xpedra Resources Ltd (PK) (VOYRF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.0136

( - )

買値

0.0136

売値

0.0136

出来高

-

0.00 日の範囲 0.00

0.0136 52 週間の範囲 0.045

時価総額

前日終値

0.0136

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 2,184,735

発行済株式数

746,472,361

配当利回り

PER

-0.72

1 株当たり利益 (EPS)

-0.03

歳入

312.36k

純利益

-12.53M

Xpedra Resources Limited, together with its subsidiaries, engages in the acquisition and exploration of mineral resource properties in Peru and Canada. The company explores for uranium, lithium, copper, antimony-gold, silver, precious mineral, and rare earth element deposits. The company was formerl... Xpedra Resources Limited, together with its subsidiaries, engages in the acquisition and exploration of mineral resource properties in Peru and Canada. The company explores for uranium, lithium, copper, antimony-gold, silver, precious mineral, and rare earth element deposits. The company was formerly known as Thunderbird Resources Limited and changed its name to Xpedra Resources Limited in December 2025. Xpedra Resources Limited was incorporated in 1996 and is based in Perth, Australia. 詳細を表示

セクター

Real Estate

業界

Real Estate

ウェブサイト

xpedraresources.com

本社

Perth, Australia

設立

1996

Xpedra Resources Ltd (PK) is listed in the Real Estate sector of the その他OTC with ticker VOYRF. The last closing price for Xpedra Resources (PK) was US$0.01. Over the last year, Xpedra Resources (PK) shares have traded in a share price range of US$ 0.0136 to US$ 0.045.

Xpedra Resources (PK) currently has 746,472,361 shares in issue. The market capitalisation of Xpedra Resources (PK) is US$10.15 million. Xpedra Resources (PK) has a price to earnings ratio (PE ratio) of -0.72.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.0136	0.0136	0.0136	0	0	CS
26	0	0	0.0136	0.0136	0.0136	0	0	CS
52	-0.0314	-69.7777777778	0.045	0.045	0.0136	789	0.0136	CS
156	0.0116	580	0.002	0.074	0.002	3092	0.00637312	CS
260	0.0016	13.3333333333	0.012	0.074	0.002	6184	0.01183175	CS

VOYRF - Frequently Asked Questions (FAQ)

What is the current Xpedra Resources Ltd (PK) share price?

The current share price of Xpedra Resources Ltd (PK) is US$ 0.0136

How many Xpedra Resources Ltd (PK) shares are in issue?

Xpedra Resources Ltd (PK) has 746,472,361 shares in issue

What is the market cap of Xpedra Resources Ltd (PK)?

The market capitalisation of Xpedra Resources Ltd (PK) is USD 10.15M

What is the 1 year trading range for Xpedra Resources Ltd (PK) share price?

Xpedra Resources Ltd (PK) has traded in the range of US$ 0.0136 to US$ 0.045 during the past year

What is the PE ratio of Xpedra Resources Ltd (PK)?

The price to earnings ratio of Xpedra Resources Ltd (PK) is -0.72

What is the cash to sales ratio of Xpedra Resources Ltd (PK)?

The cash to sales ratio of Xpedra Resources Ltd (PK) is 47.8

What is the registered address of Xpedra Resources Ltd (PK)?

The registered address for Xpedra Resources Ltd (PK) is 101 St Georges Terrace, Perth, Western Australia, 6000

What is the Xpedra Resources Ltd (PK) website address?

The website address for Xpedra Resources Ltd (PK) is xpedraresources.com

Which industry sector does Xpedra Resources Ltd (PK) operate in?

Xpedra Resources Ltd (PK) operates in the Real Estate sector

j e d

This is the biggest thing since the Advent acquisition, if not bigger.

JAB65

Never thought about that. That would certainly save them a few hundred million. Is there enough capacity, compression or whatever the criteria is to piggyback on Williams? Would they prefer to have their own control with a new station?

fredscott36

fredscott36 2分前

..dude......will get 'em both, and the G-wagon is ordered, and the 4-runner......not firm on the wrangler, but definitely a wrangler............gotta fill up the garages with a new fleet.........boys toys................($40mios in the tip jar??)...............

.....the POS.....???.

US Market News

US Market News 3分前

Robert Half receives three Canadian HR Reporter Readers' Choice Awards 2026, for 11th consecutive yearJuly 3, 2026 12:38 PM
PR Newswire (Canada) class="legendSpanClass"TORONTO, class="legendSpanClass"July 3, 2026 /CNW/ - Global talent so

KeepItRealistic

KeepItRealistic 4分前

$OSRH to new long investors buy 10k shares and HOLD and while turning your 10k shares to 60k shares 👇

• Details: One non-transferable CVR per share held as of the record date (targeted for July 31, 2026). Subject to legal counsel approval.

• Tiered Rewards: T

williamssc

williamssc 6分前

Slide16 “Overall Conclusions: The survival benefit associated with DCVax-L treatment reflects a true treatment affect and was underestimated in the original analysis”

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

NASDAQ2020

NASDAQ2020 8分前

i will wait for Monday to grab some more ??

GoodGuyBill

GoodGuyBill 8分前

Brazen22, you’re trying to reduce three years of regulatory progress to one sentence: “You don’t have an approved MAA.”

Of course we don’t — yet. Approval is the destination. We have a validated MAA. What matters is whether NWBO has completed the steps that regulators require before a

NASDAQ2020

NASDAQ2020 8分前

THATS WHEN i ACCUMULATE. At The hammerbottom.

nowwhat2

nowwhat2 8分前

Nonbelievers . . . . . C L E A R The R U N W A Y
$3.50 CDN is pretty strong support.

https://investorshub.advfn.com/uimage/uploads/2026/7/3/vwgethg_july_3_2y_plunge_sell.jpg

rizona

rizona 10分前

Slides! JAMA study UNDERESTIMATED survival benefit

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

rosemountbomber

rosemountbomber 11分前

I agree with your thinking and also what needs to be considered is after decimating the board, just a desire to be acquired doesn’t automatically make that happen. Some other party has to be interested in acquiring Amarin. What happens then if no one steps up?

chereb19

chereb19 12分前

This is another post built on false equivalence. Sharing Y-90 doesn't make two products the same any more than sharing aspirin makes every painkiller identical.

You keep calling them competitors while ignoring they're fundamentally different technologies. One is a hydrogel platform, t

NASDAQ2020

NASDAQ2020 13分前

Im glad I held my shares past $0.15

Idunno

Idunno 13分前

And don’t forget your buddy, AF. … .. .

Doc logic

Doc logic 13分前

HappyLibrarian,

You are mistakenly overstating my claim which is a common problem so no harm no foul. Manufacturing transition preparedness is what I am suggesting must be in place. Artisan will be utilized to start as NWBO has consistently stated and the MIA is based on that model.

rcaselli

rcaselli 14分前

Just knowing JCTB1 is here is good enuf for me, okay.
See ya all topside….
$LBRG

Idunno

Idunno 14分前

Have at it Brazen! ;) … .. . :)

CatfishHunter

CatfishHunter 16分前

Every biotech founder believes their design choice was the right one — that’s true of BetaGlue’s surgeon-founder and it was true of Fisher/Korenko too. Design rationale explains intent, not outcome. The question that matters is what the trial data shows for each product, not why either team picked t

asp42001

asp42001 16分前

Digital USIO & AI Payment Potential:

(USIO In-Part):

"Embedded payments are the hidden engine under the hood of the apps and platforms we use every day. When you buy a ticket through a sports app or pay for a round of golf lessons online, embedded payments are doing the

BigBadWolf

BigBadWolf 17分前

$Ownership😘 of @ this point w/ irrefutable DD
🤔https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177573771&txt2find=reactor

mgland

mgland 18分前

https://x.com/thommic/status/2072760144774005081

GTF

Just so you know the clock on the 12 month restricted period for SNTX divvy shares began on June 17th, 2026. It doesn't matter that the deliverance of shares to the gtvh shareholders is taking some time. The clock begins when SNTX creates and issues the shares...meaning the day OTCmarkets shows the

manibiotech

manibiotech 20分前

I like this line in couple of PSM analysis slides:

“ Conclusion: Based on these more precisely matched comparisons,
the survival benefit with DCVax-L was likely underestimated
in the original analysis”

Very encouraging . Now let’s see when MHRA does its jo

Xpedra Resources (PK)

Vanguard FTSE CDN Capped... (EM)

Reitmans Cda (PK)

Community Bancorp of San... (QX)

Janus Henderson

Peak Processing

Invictus Energy

Provaris Energy

Classic Minerals

Lifeist Wellness

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。